tyrphostin ag 1024 has been researched along with u 0126 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruno, V; Caraci, F; Cataldo, S; Copani, A; De Bona, P; Garozzo, D; Giuffrida, ML; Messina, A; Molinaro, G; Nicoletti, F; Palmigiano, A; Pappalardo, G; Pignataro, B; Rizzarelli, E | 1 |
| Belemnaba, L; Bucher, B; Galzi, JL; Lecat, S | 1 |
| Kearns, P; Stankovic, T; Wei, W; Weston, VJ | 1 |
3 other study(ies) available for tyrphostin ag 1024 and u 0126
| Article | Year |
|---|---|
Beta-amyloid monomers are neuroprotective.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Butadienes; Cell Death; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Excitatory Amino Acid Agonists; N-Methylaspartate; Neurons; Neuroprotective Agents; Nitriles; Peptide Fragments; Podophyllotoxin; Rats; Tyrphostins | 2009 |
Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor.
Topics: Butadienes; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gq-G11; HEK293 Cells; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neuropeptide Y; Nitriles; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Receptor, IGF Type 1; Receptor, IGF Type 2; Receptors, Neuropeptide Y; Signal Transduction; Transcriptional Activation; Tyrphostins | 2015 |
Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1.
Topics: Butadienes; Cell Cycle; Chromones; Daunorubicin; Down-Regulation; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; Humans; Intercellular Signaling Peptides and Proteins; MAP Kinase Kinase Kinase 1; Morpholines; Neoplasm Proteins; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Receptor, IGF Type 1; RNA Interference; RNA, Small Interfering; Signal Transduction; STAT6 Transcription Factor; Tumor Cells, Cultured; Tyrphostins; Vincristine | 2018 |